Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 609-12-1
2. Ethyl 2-bromo-3-methylbutanoate
3. Ethyl 2-bromo-3-methylbutyrate
4. Butanoic Acid, 2-bromo-3-methyl-, Ethyl Ester
5. Ethyl .alpha.-bromoisovalerate
6. Ethyl Alpha-bromoisovalerate
7. 2-bromoisovaleric Acid Ethyl Ester
8. Butyric Acid, 2-bromo-3-methyl-, Ethyl Ester
9. Nsc-8866
10. .alpha.-bromoisovaleric Acid Ethyl Ester
11. 2-bromo-3-methyl-butyric Acid Ethyl Ester
12. 4j9877130m
13. Ethyl 2-bromo Isovalerate
14. Alpha-bromoisovaleric Acid Ethyl Ester
15. Ethyl 2-bromo-3-methyl-butanoate
16. Unii-4j9877130m
17. Nsc 8866
18. Einecs 210-178-3
19. Ethyl A-bromoisovalerate
20. Ethyl-2-bromoisovalerate
21. Ai3-52374
22. 2-bromoisovalerianic Acid Ethyl Ester
23. Ethyl 2-bromoisopentanoate
24. Schembl89146
25. Ethyl2-bromo-3-methylbutanoate
26. Ethyl-2-bromo-3-methylbutyrate
27. 2-bromo Isovaleric Acid
28. Dtxsid20870681
29. Nsc8866
30. Ethyl-2-bromo-3-methyl-butanoate
31. Act02956
32. Mfcd00026855
33. Stl452992
34. Akos003625012
35. Akos016842351
36. Cs-w022654
37. Sb13077
38. 3-(2-chlorophenyl)-1h-indol-5-amine
39. 2-bromo-3-methylbutyric Acid Ethyl Ester
40. Bp-13193
41. Ethyl 2-bromoisovalerate [who-dd]
42. Db-053738
43. Ethyl 2-bromo-3-methylbutyrate, Aldrichcpr
44. Am20100480
45. E0969
46. Ft-0602541
47. En300-40930
48. 2-bromo-3-methylbutanoic Acid Ethyl Ester
49. W-105222
50. Q27259740
| Molecular Weight | 209.08 g/mol |
|---|---|
| Molecular Formula | C7H13BrO2 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 208.00989 g/mol |
| Monoisotopic Mass | 208.00989 g/mol |
| Topological Polar Surface Area | 26.3 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 112 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Ethyl 2-Bromoisovalerate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ethyl 2-Bromoisovalerate, including repackagers and relabelers. The FDA regulates Ethyl 2-Bromoisovalerate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ethyl 2-Bromoisovalerate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ethyl 2-Bromoisovalerate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ethyl 2-Bromoisovalerate supplier is an individual or a company that provides Ethyl 2-Bromoisovalerate active pharmaceutical ingredient (API) or Ethyl 2-Bromoisovalerate finished formulations upon request. The Ethyl 2-Bromoisovalerate suppliers may include Ethyl 2-Bromoisovalerate API manufacturers, exporters, distributors and traders.
click here to find a list of Ethyl 2-Bromoisovalerate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ethyl 2-Bromoisovalerate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ethyl 2-Bromoisovalerate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ethyl 2-Bromoisovalerate GMP manufacturer or Ethyl 2-Bromoisovalerate GMP API supplier for your needs.
A Ethyl 2-Bromoisovalerate CoA (Certificate of Analysis) is a formal document that attests to Ethyl 2-Bromoisovalerate's compliance with Ethyl 2-Bromoisovalerate specifications and serves as a tool for batch-level quality control.
Ethyl 2-Bromoisovalerate CoA mostly includes findings from lab analyses of a specific batch. For each Ethyl 2-Bromoisovalerate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ethyl 2-Bromoisovalerate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ethyl 2-Bromoisovalerate EP), Ethyl 2-Bromoisovalerate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ethyl 2-Bromoisovalerate USP).
LOOKING FOR A SUPPLIER?
